[HTML][HTML] Nanovaccines: a game changing approach in the fight against infectious diseases
The field of nanotechnology has revolutionised global attempts to prevent, treat, and
eradicate infectious diseases in the foreseen future. Nanovaccines have proven to be a …
eradicate infectious diseases in the foreseen future. Nanovaccines have proven to be a …
Advancements in prophylactic and therapeutic nanovaccines
Vaccines activate suitable immune responses to fight against diseases but can possess
limitations such as compromised efficacy and immunogenic responses, poor stability, and …
limitations such as compromised efficacy and immunogenic responses, poor stability, and …
Ether lipids from archaeas in nano-drug delivery and vaccination
EL Romero, MJ Morilla - International Journal of Pharmaceutics, 2023 - Elsevier
Archaea are microorganisms more closely related to eukaryotes than bacteria. Almost 50
years after being defined as a new domain of life on earth, new species continue to be …
years after being defined as a new domain of life on earth, new species continue to be …
Vaccine approaches for antigen capture by liposomes
Introduction Liposomes have been used as carriers for vaccine adjuvants and antigens due
to their inherent biocompatibility and versatility as delivery vehicles. Two vial admixture of …
to their inherent biocompatibility and versatility as delivery vehicles. Two vial admixture of …
An overview of the development of new vaccines for tuberculosis
E Whitlow, AS Mustafa, SNM Hanif - Vaccines, 2020 - mdpi.com
Currently, there is only one licensed vaccine against tuberculosis (TB), the Bacillus Calmette–
Guérin (BCG). Despite its protective efficacy against TB in children, BCG has failed to protect …
Guérin (BCG). Despite its protective efficacy against TB in children, BCG has failed to protect …
Host immune responses to mycobacterial antigens and their implications for the development of a vaccine to control tuberculosis
JM Yuk, EK Jo - Clinical and experimental vaccine research, 2014 - synapse.koreamed.org
Tuberculosis (TB) remains a worldwide health problem, causing around 2 million deaths per
year. Despite the bacillus Calmette Guérin vaccine being available for more than 80 years, it …
year. Despite the bacillus Calmette Guérin vaccine being available for more than 80 years, it …
A comparison of the immune responses induced by antigens in three different archaeosome-based vaccine formulations
Y Jia, B Akache, L Deschatelets, H Qian… - International journal of …, 2019 - Elsevier
Archaeosomes are liposomes composed of natural or synthetic archaeal lipids that can be
used as adjuvants to induce strong long-lasting humoral and cell-mediated immune …
used as adjuvants to induce strong long-lasting humoral and cell-mediated immune …
Archaeosomes and gas vesicles as tools for vaccine development
N Adamiak, KT Krawczyk, C Locht… - Frontiers in …, 2021 - frontiersin.org
Archaea are prokaryotic organisms that were classified as a new domain in 1990. Archaeal
cellular components and metabolites have found various applications in the pharmaceutical …
cellular components and metabolites have found various applications in the pharmaceutical …
[HTML][HTML] Archaeal glycolipid adjuvanted vaccines induce strong influenza-specific immune responses through direct immunization in young and aged mice or through …
Vaccine induced responses are often weaker in those individuals most susceptible to
infection, namely the very young and the elderly, highlighting the need for safe and effective …
infection, namely the very young and the elderly, highlighting the need for safe and effective …
Simplified admix archaeal glycolipid adjuvanted vaccine and checkpoint inhibitor therapy combination enhances protection from murine melanoma
Archaeosomes are liposomes composed of natural or synthetic archaeal lipids that when
used as adjuvants induce strong long-lasting humoral and cell-mediated immune responses …
used as adjuvants induce strong long-lasting humoral and cell-mediated immune responses …